Lv1
40 积分 2023-12-05 加入
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165
5小时前
已完结
Pharmacologic restoration of GTP hydrolysis by mutant RAS
4天前
已完结
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-d]pyrimidine Scaffold
14天前
已完结
E3 ligase ligand chemistries: from building blocks to protein degraders
16天前
已完结
Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein–Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases
25天前
已完结
Structure-based design of non-hypertrophic apelin receptor modulator
30天前
已完结
Targeting Gatekeeper Mutations for Kinase Drug Discovery
1个月前
已完结
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
1个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
1个月前
已完结
Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein–Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases
1个月前
已完结
皖公网安备34019202002308
